Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways
iPSC-MSCs protect against oxidative stress-induced mitochondrial dysfunction, apoptosis, hyper-responsiveness and inflammation in the airways. These findings highlight the potential use of iPSC-MScs as a novel cell-based therapy for COPD.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Xiang Li, Charalambos Michaeloudes, Yuelin Zhang, Coen H. Wiegman, Ian M. Adcock, Qizhou Lian, Judith C.W. Mak, Pankaj K. Bhavsar, Kian Fan Chung Source Type: research
More News: Allergy | Allergy & Immunology | Chronic Obstructive Pulmonary | Stem Cell Therapy | Stem Cells